NICHOLAS YOZAMP: Open Payments
NPI 1275914475 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 24 payments from 10 companies in 2025. Trend: 2023 $854 · 2024 $1,295 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $113 |
| Abbott Laboratories | 4 | $92 |
| Lilly USA, LLC | 4 | $78 |
| Amgen Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Radius Health, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: FREESTYLE LIBRE 3, Ozempic, REPATHA, MOUNJARO, FARXIGA, JARDIANCE, Rybelsus, Tymlos.
Industry payments across MO — which companies pay providers there.
